At ANTG we believe that all Australians should be able to benefit from high-quality, affordable, locally-produced prescription medicines that have been created to the highest possible standard.
Our medicinal cannabis products are Australian grown and Australian made, cultivated and manufactured to Good Manufacturing Practices (GMP) and Good Agricultural and Collection Practices (GACP) standards. We are the first and only Australian medicinal cannabis company to receive these accreditations for medicinal cannabis flower manufacturing, certifying our products meet the highest pharmaceutical standards worldwide.
Our products also conform with the Therapeutic Goods Standards for Medicinal Cannabis (TG093 & TG0100) ensuring they are free from harmful contaminants such as moulds, microbials and yeast.
Our team of master growers and plant scientists have years of experience, producing consistent high-quality medicinal cannabis with a variable ratio of CBD and THC – allowing treatments to be tailored to individual patient needs.
Our medicinal cannabis plants are grown under the sun, in an all natural, renewable medium, without harmful chemical pesticides.
We currently have three medicinal cannabis flower strains available on prescription under the following Therapeutic Goods Administration (TGA) schemes:
Special Access Scheme (Category A);
Special Access Scheme (Category B);
Authorised Prescriber Scheme;
Clinical Trial Notification Scheme.
ANTG’s medicinal cannabis products are available with an approved prescription via the TGA’s Special Access Scheme or via Authorised Prescriber applications.
For more information about our medicinal cannabis products, healthcare providers can contact us on [email protected]
We have three medicinal cannabis flower products listed on the Australian Register of Therapeutic Goods (ARTG) for export. Listing on the ARTG allows our products to be lawfully exported from Australia to overseas patients. Our medicinal cannabis flower is currently contracted for distribution throughout Germany and the European Union.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >